Welcome to our dedicated page for Sunlink Hlth SEC filings (Ticker: SSY), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings archive for SunLink Health Systems, Inc. (SSY) provides a detailed regulatory record of the company’s operations, strategic shift, and eventual merger into Regional Health Properties, Inc. Investors can use these documents to understand how SunLink described its pharmacy and healthcare businesses, managed asset sales, and structured the transaction that ended SSY’s life as a standalone public company.
Key filings include multiple Forms 8-K that outline material events. An 8-K dated June 23, 2025 describes the amendment to the Amended and Restated Agreement and Plan of Merger between SunLink and Regional, extending the merger termination date. Subsequent 8-K and 8-K/A filings in July 2025 furnish press releases about proxy voting for the merger, updates on a special cash dividend, and the mechanics of due bill procedures for that dividend. An 8-K dated July 29, 2025 reports on the adjournment and reconvening of SunLink’s special meeting of shareholders to vote on the merger proposals.
The Form 8-K filed on August 14, 2025 is central to understanding the transaction. It explains that SunLink completed its merger with and into Regional on that date, with Regional surviving as the continuing corporation. The filing details the share conversion terms, including how each five shares of SunLink common stock were converted into rights to receive Regional common stock and Regional Series D 8% Cumulative Convertible Redeemable Participating Preferred Shares, with cash in lieu of fractional shares. It also notes that SunLink shareholders ceased to have rights as SunLink shareholders other than receiving the merger consideration and that a change in control occurred.
Trading and reporting status changes are documented in subsequent filings. A Form 25 filed by NYSE American on August 15, 2025 notifies the SEC of the removal of SunLink’s common stock from listing and registration on NYSE American. A Form 15 filed on August 26, 2025 certifies the termination of registration of SunLink’s common stock under Section 12(g) of the Exchange Act and the suspension of its reporting obligations under Sections 13 and 15(d), citing the completion of the merger with Regional.
Alongside these event-driven reports, SunLink’s periodic filings (such as Forms 10-K and 10-Q, referenced in its news releases) provide historical financial statements and segment information, including the prominence of pharmacy net revenues and the impact of discontinued operations related to hospital and senior care asset sales. On this page, AI-powered tools can help summarize complex filings, highlight the portions that describe the merger terms, delisting steps, and deregistration, and guide users to the specific sections that address share exchange ratios, special cash dividends, and conditions to closing.
Together, these filings form a comprehensive regulatory history of SSY, from its role as a Southeast-focused healthcare and pharmacy company to its integration into Regional Health Properties, Inc. and the subsequent delisting and deregistration of its common stock.
SunLink Health Systems, Inc. submitted a Form 25 notifying the removal of its securities from NYSE American LLC. The filing names the issuer as SunLink Health Systems Inc and the exchange as NYSE AMERICAN LLC. The document is a formal notification under the Securities Exchange Act of 1934 that the class of securities will be struck from listing and/or registration. The filing includes the issuer's principal office address at 900 Circle 75 Parkway, Suite 1300, Atlanta, Georgia 30339 and a contact phone number 770-933-7000. The form cites compliance with the Exchange and SEC procedures for removal, referencing the applicable rule provisions for withdrawal.
Ford C. Michael, an officer of SunLink Health Systems, Inc. (SSY), reported transactions on 08/14/2025 related to a corporate merger. The filing shows a disposition of 49,422 shares of SunLink common stock, leaving the reporting person with 0 shares of common stock following the transaction. The filing also reports dispositions of three director stock options (5,000; 12,000; and 10,000 options) that each had specified exercise prices and expiration dates and are shown as resulting in 0 options beneficially owned after the transactions. The explanatory note states that at the effective time of the merger between SunLink and Regional Health Properties, Inc., each five shares of SunLink common stock were converted into 1.1330 shares of Regional common stock plus one share of a Series D preferred of Regional, and that an option was terminated in the merger. The Form 4 was executed by M. Timothy Elder pursuant to power of attorney on 08/14/2025.
Sheila G. Brockman, listed with an Atlanta address, filed a Form 4 regarding SunLink Health Systems, Inc. (SSY) with an earliest transaction date of 08/14/2025. The filing identifies her relationship to the issuer as an Officer and notes she is a former VP of SSY and CEO of a subsidiary. The form does not include any populated transaction tables or disclose the type, quantity, or price of securities traded; the signature block shows execution by M. Timothy Elder under power of attorney on 08/14/2025.
Insider dispositions and merger conversion reported for SunLink Health Systems, Inc. (SSY). Gene E. Burleson reported that on 08/14/2025 he disposed of 81,601 shares of SunLink common stock and an additional 10,000 shares that were held indirectly, leaving zero shares beneficially owned directly after the transactions. A director stock option for 5,000 shares (exercise price $1.79) was disposed/terminated in the same transaction.
The filing explains these changes arose at the effective time of a merger between SunLink and Regional Health Properties, Inc.: each five SunLink shares were converted into the right to receive 1.1330 shares of Regional common stock and one share of Series D 8% cumulative convertible redeemable participating preferred stock of Regional. The form was signed by power of attorney on 08/14/2025.
Steven J. Baileys, a reporting person for SunLink Health Systems, Inc. (SSY), reported multiple dispositions on 08/14/2025 that reduced his beneficial ownership in SunLink to 0 shares. The Form 4 shows sales/dispositions of 832,844 common shares in aggregate (551,244 + 50,000 + 50,000 + 180,000 + 1,600), and the filing notes these changes occurred at the effective time of a merger between SunLink and Regional Health Properties, Inc., under which SunLink shares were converted into Regional common stock and a Series D preferred share right per the merger terms. Several director stock options (5,000; 12,000; 10,000) were recorded as disposed/terminated in the merger, leaving 0 underlying shares held after the transactions.
SunLink Health Systems insider reporting: disposition of common stock tied to merger conversion. The filing shows that Mark J. Stockslager, identified as a former director and former CFO/accounting officer, reported a disposition on 08/14/2025 of 108,051 shares of SunLink common stock, resulting in 0 shares beneficially owned following the transaction. The explanation states that at the effective time of the merger between SunLink and Regional Health Properties, each five SunLink shares were converted into 1.1330 shares of Regional common stock plus one share of Series D preferred of Regional. The Form 4 was signed via power of attorney.
Robert M. Thornton Jr. reported dispositions of SunLink Health Systems, Inc. (SSY) common stock on 08/14/2025 in a transaction tied to a merger with Regional Health Properties, Inc. The Form 4 shows two dispositions: 554,562 shares and 5,000 shares (the latter held in an IRA), leaving 0 shares beneficially owned following the reported transactions. The filing explains that at the merger Effective Time each five SunLink shares were converted into 1.1330 shares of Regional common stock plus one share of Series D 8% cumulative convertible redeemable participating preferred stock of Regional. The 554,562 shares are reported as owned indirectly by CareVest Capital, L.L.C., of which Mr. Thornton owns 100% of the voting shares and is reporting CareVest’s holdings.